Piramal Enterprises Mergers & Acquisitions

Piramal Enterprises M&A Summary

Piramal Enterprises has acquired 12 companies, including 1 in the last 5 years. A total of 4 acquisitions came from private equity firms. It has also divested 3 assets.

Piramal Enterprises’ largest acquisition to date was in 2012, when it acquired Decision Resources for $635M. It’s largest disclosed sale occurred in 2010, when it sold Piramal Healthcare Generic Drugs to Abbott Laboratories for $3.7B. Piramal Enterprises has acquired in 5 different US states, and 4 countries. The Company’s most targeted sectors include life science (50%) and medical products (17%).

M&A Summary

  • M&A Total Activity15
    • M&A Buy Activity12
    • M&A Sell Activity3
  • Total Sectors Invested 5
  • Total Countries Invested 4
  • M&A Buy/Sell Connections 9

Piramal Enterprises

Piramal Enterprises Ltd.

Piramal Ananta, Agastya Corporate Park 109 A, 109A/1 to 109/21A, 111 and 110, 110/1 to 110/13 Opposite Fire Brigade, Kamani Junction LBS Marg, Kurla (West),
Mumbai, 400070
India,
+91 22 3802 3000
www.piramal.com

All (15) Buy (12) Sell (3)
Date Target Value
$mlns
Transaction Type Acquirer Seller SRC
Link
2021-03-31 Hemmo Pharmaceutical · Medical Products
Mumbai, India · www.hemmopharma.com

Hemmo Pharmaceutical develops and manufactures peptide APIs. Its portfolio covers 30+ APIs including generic peptides, peptide NCEs and peptides in clinical development which it offers to pharma and research companies in both domestic and global markets. Hemmo Pharmaceutical was founded in 1979 and is based in Mumbai, India.

Advisor: Torreya Partners
- Add-on Acquisition

Piramal Enterprises
Advisors: Economic Laws Practice , Kotak Investment Banking

-

Try Mergr Free — See This and 220,453+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 82K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.